Kendall Capital Management Bausch Health Companies Inc. Transaction History
Kendall Capital Management
- $329 Million
- Q1 2025
A detailed history of Kendall Capital Management transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Kendall Capital Management holds 15,225 shares of BHC stock, worth $80,692. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,225
Previous 17,995
15.39%
Holding current value
$80,692
Previous $145,000
32.41%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
273Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$184 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$146 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$140 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$81.7 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$68.9 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.92B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...